List of Tables
Table 1. Global CAR-T Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global CAR-T Drugs Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global CAR-T Drugs Market Competitive Situation by Manufacturers in 2024
Table 4. Global CAR-T Drugs Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global CAR-T Drugs Sales Market Share by Manufacturers (2020-2025)
Table 6. Global CAR-T Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global CAR-T Drugs Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market CAR-T Drugs Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of CAR-T Drugs, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of CAR-T Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of CAR-T Drugs, Product Type & Application
Table 12. Global Key Manufacturers of CAR-T Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global CAR-T Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CAR-T Drugs as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global CAR-T Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global CAR-T Drugs Sales by Region (2020-2025) & (K Units)
Table 18. Global CAR-T Drugs Sales Market Share by Region (2020-2025)
Table 19. Global CAR-T Drugs Sales by Region (2026-2031) & (K Units)
Table 20. Global CAR-T Drugs Sales Market Share by Region (2026-2031)
Table 21. Global CAR-T Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global CAR-T Drugs Revenue Market Share by Region (2020-2025)
Table 23. Global CAR-T Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global CAR-T Drugs Revenue Market Share by Region (2026-2031)
Table 25. North America CAR-T Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America CAR-T Drugs Sales by Country (2020-2025) & (K Units)
Table 27. North America CAR-T Drugs Sales by Country (2026-2031) & (K Units)
Table 28. North America CAR-T Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America CAR-T Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe CAR-T Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe CAR-T Drugs Sales by Country (2020-2025) & (K Units)
Table 32. Europe CAR-T Drugs Sales by Country (2026-2031) & (K Units)
Table 33. Europe CAR-T Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe CAR-T Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific CAR-T Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific CAR-T Drugs Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific CAR-T Drugs Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific CAR-T Drugs Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific CAR-T Drugs Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America CAR-T Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America CAR-T Drugs Sales by Country (2020-2025) & (K Units)
Table 42. Latin America CAR-T Drugs Sales by Country (2026-2031) & (K Units)
Table 43. Latin America CAR-T Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America CAR-T Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa CAR-T Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa CAR-T Drugs Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa CAR-T Drugs Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa CAR-T Drugs Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa CAR-T Drugs Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global CAR-T Drugs Sales (K Units) by Type (2020-2025)
Table 51. Global CAR-T Drugs Sales (K Units) by Type (2026-2031)
Table 52. Global CAR-T Drugs Sales Market Share by Type (2020-2025)
Table 53. Global CAR-T Drugs Sales Market Share by Type (2026-2031)
Table 54. Global CAR-T Drugs Revenue (US$ Million) by Type (2020-2025)
Table 55. Global CAR-T Drugs Revenue (US$ Million) by Type (2026-2031)
Table 56. Global CAR-T Drugs Revenue Market Share by Type (2020-2025)
Table 57. Global CAR-T Drugs Revenue Market Share by Type (2026-2031)
Table 58. Global CAR-T Drugs Price (US$/Unit) by Type (2020-2025)
Table 59. Global CAR-T Drugs Price (US$/Unit) by Type (2026-2031)
Table 60. Global CAR-T Drugs Sales (K Units) by Application (2020-2025)
Table 61. Global CAR-T Drugs Sales (K Units) by Application (2026-2031)
Table 62. Global CAR-T Drugs Sales Market Share by Application (2020-2025)
Table 63. Global CAR-T Drugs Sales Market Share by Application (2026-2031)
Table 64. Global CAR-T Drugs Revenue (US$ Million) by Application (2020-2025)
Table 65. Global CAR-T Drugs Revenue (US$ Million) by Application (2026-2031)
Table 66. Global CAR-T Drugs Revenue Market Share by Application (2020-2025)
Table 67. Global CAR-T Drugs Revenue Market Share by Application (2026-2031)
Table 68. Global CAR-T Drugs Price (US$/Unit) by Application (2020-2025)
Table 69. Global CAR-T Drugs Price (US$/Unit) by Application (2026-2031)
Table 70. Novartis Company Information
Table 71. Novartis Description and Business Overview
Table 72. Novartis CAR-T Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Novartis CAR-T Drugs Product
Table 74. Novartis Recent Developments/Updates
Table 75. Gilead Sciences Company Information
Table 76. Gilead Sciences Description and Business Overview
Table 77. Gilead Sciences CAR-T Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Gilead Sciences CAR-T Drugs Product
Table 79. Gilead Sciences Recent Developments/Updates
Table 80. WuXi Biologics Company Information
Table 81. WuXi Biologics Description and Business Overview
Table 82. WuXi Biologics CAR-T Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. WuXi Biologics CAR-T Drugs Product
Table 84. WuXi Biologics Recent Developments/Updates
Table 85. Sanofi Company Information
Table 86. Sanofi Description and Business Overview
Table 87. Sanofi CAR-T Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Sanofi CAR-T Drugs Product
Table 89. Sanofi Recent Developments/Updates
Table 90. Juno Therapeutics Company Information
Table 91. Juno Therapeutics Description and Business Overview
Table 92. Juno Therapeutics CAR-T Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Juno Therapeutics CAR-T Drugs Product
Table 94. Juno Therapeutics Recent Developments/Updates
Table 95. Bluebird Bio Company Information
Table 96. Bluebird Bio Description and Business Overview
Table 97. Bluebird Bio CAR-T Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Bluebird Bio CAR-T Drugs Product
Table 99. Bluebird Bio Recent Developments/Updates
Table 100. Cellectis Company Information
Table 101. Cellectis Description and Business Overview
Table 102. Cellectis CAR-T Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Cellectis CAR-T Drugs Product
Table 104. Cellectis Recent Developments/Updates
Table 105. Precision Biosciences Company Information
Table 106. Precision Biosciences Description and Business Overview
Table 107. Precision Biosciences CAR-T Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Precision Biosciences CAR-T Drugs Product
Table 109. Precision Biosciences Recent Developments/Updates
Table 110. CRISPR Therapeutics Company Information
Table 111. CRISPR Therapeutics Description and Business Overview
Table 112. CRISPR Therapeutics CAR-T Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. CRISPR Therapeutics CAR-T Drugs Product
Table 114. CRISPR Therapeutics Recent Developments/Updates
Table 115. Autolus Therapeutics Company Information
Table 116. Autolus Therapeutics Description and Business Overview
Table 117. Autolus Therapeutics CAR-T Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Autolus Therapeutics CAR-T Drugs Product
Table 119. Autolus Therapeutics Recent Developments/Updates
Table 120. Adaptimmune Therapeutics Company Information
Table 121. Adaptimmune Therapeutics Description and Business Overview
Table 122. Adaptimmune Therapeutics CAR-T Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Adaptimmune Therapeutics CAR-T Drugs Product
Table 124. Adaptimmune Therapeutics Recent Developments/Updates
Table 125. Atara Biotherapeutics Company Information
Table 126. Atara Biotherapeutics Description and Business Overview
Table 127. Atara Biotherapeutics CAR-T Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Atara Biotherapeutics CAR-T Drugs Product
Table 129. Atara Biotherapeutics Recent Developments/Updates
Table 130. Tmunity Therapeutics Company Information
Table 131. Tmunity Therapeutics Description and Business Overview
Table 132. Tmunity Therapeutics CAR-T Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. Tmunity Therapeutics CAR-T Drugs Product
Table 134. Tmunity Therapeutics Recent Developments/Updates
Table 135. Iovance Biotherapeutics Company Information
Table 136. Iovance Biotherapeutics Description and Business Overview
Table 137. Iovance Biotherapeutics CAR-T Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. Iovance Biotherapeutics CAR-T Drugs Product
Table 139. Iovance Biotherapeutics Recent Developments/Updates
Table 140. Celyad Oncology Company Information
Table 141. Celyad Oncology Description and Business Overview
Table 142. Celyad Oncology CAR-T Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 143. Celyad Oncology CAR-T Drugs Product
Table 144. Celyad Oncology Recent Developments/Updates
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. CAR-T Drugs Distributors List
Table 148. CAR-T Drugs Customers List
Table 149. CAR-T Drugs Market Trends
Table 150. CAR-T Drugs Market Drivers
Table 151. CAR-T Drugs Market Challenges
Table 152. CAR-T Drugs Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
Table 156. Authors List of This Report
List of Figures
Figure 1. Product Picture of CAR-T Drugs
Figure 2. Global CAR-T Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global CAR-T Drugs Market Share by Type: 2024 & 2031
Figure 4. CD19 CAR-T Product Picture
Figure 5. BCMACAR-T Product Picture
Figure 6. Others Product Picture
Figure 7. Global CAR-T Drugs Market Value by Application (2020-2031) & (US$ Million)
Figure 8. Global CAR-T Drugs Market Share by Application: 2024 & 2031
Figure 9. Hematoma
Figure 10. Solid Tumors
Figure 11. Others
Figure 12. Global CAR-T Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global CAR-T Drugs Market Size (2020-2031) & (US$ Million)
Figure 14. Global CAR-T Drugs Sales (2020-2031) & (K Units)
Figure 15. Global CAR-T Drugs Average Price (US$/Unit) & (2020-2031)
Figure 16. CAR-T Drugs Report Years Considered
Figure 17. CAR-T Drugs Sales Share by Manufacturers in 2024
Figure 18. Global CAR-T Drugs Revenue Share by Manufacturers in 2024
Figure 19. Global 5 and 10 Largest CAR-T Drugs Players: Market Share by Revenue in CAR-T Drugs in 2024
Figure 20. CAR-T Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 21. Global CAR-T Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 22. North America CAR-T Drugs Sales Market Share by Country (2020-2031)
Figure 23. North America CAR-T Drugs Revenue Market Share by Country (2020-2031)
Figure 24. United States CAR-T Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Canada CAR-T Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Europe CAR-T Drugs Sales Market Share by Country (2020-2031)
Figure 27. Europe CAR-T Drugs Revenue Market Share by Country (2020-2031)
Figure 28. Germany CAR-T Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. France CAR-T Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. U.K. CAR-T Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Italy CAR-T Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Russia CAR-T Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Asia Pacific CAR-T Drugs Sales Market Share by Region (2020-2031)
Figure 34. Asia Pacific CAR-T Drugs Revenue Market Share by Region (2020-2031)
Figure 35. China CAR-T Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Japan CAR-T Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. South Korea CAR-T Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. India CAR-T Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Australia CAR-T Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. China Taiwan CAR-T Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Southeast Asia CAR-T Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Latin America CAR-T Drugs Sales Market Share by Country (2020-2031)
Figure 43. Latin America CAR-T Drugs Revenue Market Share by Country (2020-2031)
Figure 44. Mexico CAR-T Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Brazil CAR-T Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Argentina CAR-T Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Middle East and Africa CAR-T Drugs Sales Market Share by Country (2020-2031)
Figure 48. Middle East and Africa CAR-T Drugs Revenue Market Share by Country (2020-2031)
Figure 49. Turkey CAR-T Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Saudi Arabia CAR-T Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. UAE CAR-T Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Global Sales Market Share of CAR-T Drugs by Type (2020-2031)
Figure 53. Global Revenue Market Share of CAR-T Drugs by Type (2020-2031)
Figure 54. Global CAR-T Drugs Price (US$/Unit) by Type (2020-2031)
Figure 55. Global Sales Market Share of CAR-T Drugs by Application (2020-2031)
Figure 56. Global Revenue Market Share of CAR-T Drugs by Application (2020-2031)
Figure 57. Global CAR-T Drugs Price (US$/Unit) by Application (2020-2031)
Figure 58. CAR-T Drugs Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
